- Home
- PTGX vs ORI Comparison
PTGX vs ORI Comparison
Compare PTGX & ORI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PTGX | ORI |
|---|---|---|
| Founded | 2006 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 9.8B |
| IPO Year | 2016 | 1994 |
Fundamental Metrics
Financial Performance| Metric | PTGX | ORI |
|---|---|---|
| Price | $139.40 | $37.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 3 |
| Target Price | ★ $174.69 | $43.50 |
| AVG Volume (30 Days) | 535.2K | ★ 1.2M |
| Earning Date | 11-05-2026 | 10-22-2026 |
| Dividend Yield | N/A | ★ 10.08% |
| EPS Growth | N/A | ★ 14.81 |
| EPS | 2.35 | ★ 2.63 |
| Revenue | N/A | ★ $9,136,300,000.00 |
| Revenue This Year | $1,078.44 | $8.72 |
| Revenue Next Year | N/A | $4.41 |
| P/E Ratio | $60.03 | ★ $14.43 |
| Revenue Growth | N/A | ★ 10.99 |
| 52 Week Low | $62.24 | $36.65 |
| 52 Week High | $160.81 | $46.76 |
Technical Indicators
Market Signals| Indicator | PTGX | ORI |
|---|---|---|
| Relative Strength Index (RSI) | 44.31 | 22.76 |
| Support Level | $132.37 | $37.04 |
| Resistance Level | $142.20 | $43.29 |
| Average True Range (ATR) | 4.59 | 0.66 |
| MACD | -0.44 | -0.23 |
| Stochastic Oscillator | 39.61 | 1.30 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
About ORI Old Republic International Corporation
Old Republic International Corp is engaged in the business of insurance underwriting and related services. The company operates in two segments: Specialty Insurance and Title Insurance. The insurance provided by the company includes Automobile Extended Warranty Insurance, Aviation, Commercial Automobile Insurance, Inland Marine, Travel Accident, Workers' Compensation, Financial Indemnity, and others. The company generates the majority of its revenue from Specialty Insurance. The Specialty Insurance provides property and liability insurance principally to commercial clients.